Clinical Trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Protocol Amendment History 240 amendments
This ClinicalTrials.gov record has been amended 240 times since 2011-05-10; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2011-10-10
Trial Details
NCT Number NCT01351545
Lead Sponsor Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program
Conditions Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML) +9 more
Enrollment 99,999 participants
Start Date 2011-10
Primary Completion 2041-10 (estimated)
Study Completion 2041-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-06